Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a minor internal update to the study page rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-05-15T05:35:50.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s displayed version/revision indicator has been incremented from “v3.5.2” to “v3.5.3,” reflecting a minor site update without changing the underlying clinical trial content.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Website revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:31:54.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a disease term and a link to the Genetic and Rare Diseases Information Center; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T20:20:20.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2. This is a metadata version update.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:17.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The prior lapse-in-government-funding operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T00:27:42.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.